First Time Loading...

DarioHealth Corp
NASDAQ:DRIO

Watchlist Manager
DarioHealth Corp Logo
DarioHealth Corp
NASDAQ:DRIO
Watchlist
Price: 1.47 USD -2% Market Closed
Updated: Apr 26, 2024

Intrinsic Value

DRIO's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

DarioHealth Corp. is a digital therapeutics company, which engages in the research, development, and sale of pharmaceutical products. [ Read More ]

The intrinsic value of one DRIO stock under the Base Case scenario is 6.21 USD. Compared to the current market price of 1.47 USD, DarioHealth Corp is Undervalued by 76%.

Key Points:
DRIO Intrinsic Value
Base Case
6.21 USD
Undervaluation 76%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
DarioHealth Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling DRIO stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
DarioHealth Corp

Provide an overview of the primary business activities
of DarioHealth Corp.

What unique competitive advantages
does DarioHealth Corp hold over its rivals?

What risks and challenges
does DarioHealth Corp face in the near future?

Has there been any significant insider trading activity
in DarioHealth Corp recently?

Summarize the latest earnings call
of DarioHealth Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for DarioHealth Corp.

Provide P/S
for DarioHealth Corp.

Provide P/E
for DarioHealth Corp.

Provide P/OCF
for DarioHealth Corp.

Provide P/FCFE
for DarioHealth Corp.

Provide P/B
for DarioHealth Corp.

Provide EV/S
for DarioHealth Corp.

Provide EV/GP
for DarioHealth Corp.

Provide EV/EBITDA
for DarioHealth Corp.

Provide EV/EBIT
for DarioHealth Corp.

Provide EV/OCF
for DarioHealth Corp.

Provide EV/FCFF
for DarioHealth Corp.

Provide EV/IC
for DarioHealth Corp.

Show me price targets
for DarioHealth Corp made by professional analysts.

What are the Revenue projections
for DarioHealth Corp?

How accurate were the past Revenue estimates
for DarioHealth Corp?

What are the Net Income projections
for DarioHealth Corp?

How accurate were the past Net Income estimates
for DarioHealth Corp?

What are the EPS projections
for DarioHealth Corp?

How accurate were the past EPS estimates
for DarioHealth Corp?

What are the EBIT projections
for DarioHealth Corp?

How accurate were the past EBIT estimates
for DarioHealth Corp?

Compare the revenue forecasts
for DarioHealth Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of DarioHealth Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of DarioHealth Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of DarioHealth Corp compared to its peers.

Compare the P/E ratios
of DarioHealth Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing DarioHealth Corp with its peers.

Analyze the financial leverage
of DarioHealth Corp compared to its main competitors.

Show all profitability ratios
for DarioHealth Corp.

Provide ROE
for DarioHealth Corp.

Provide ROA
for DarioHealth Corp.

Provide ROIC
for DarioHealth Corp.

Provide ROCE
for DarioHealth Corp.

Provide Gross Margin
for DarioHealth Corp.

Provide Operating Margin
for DarioHealth Corp.

Provide Net Margin
for DarioHealth Corp.

Provide FCF Margin
for DarioHealth Corp.

Show all solvency ratios
for DarioHealth Corp.

Provide D/E Ratio
for DarioHealth Corp.

Provide D/A Ratio
for DarioHealth Corp.

Provide Interest Coverage Ratio
for DarioHealth Corp.

Provide Altman Z-Score Ratio
for DarioHealth Corp.

Provide Quick Ratio
for DarioHealth Corp.

Provide Current Ratio
for DarioHealth Corp.

Provide Cash Ratio
for DarioHealth Corp.

What is the historical Revenue growth
over the last 5 years for DarioHealth Corp?

What is the historical Net Income growth
over the last 5 years for DarioHealth Corp?

What is the current Free Cash Flow
of DarioHealth Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for DarioHealth Corp.

Financials

Balance Sheet Decomposition
DarioHealth Corp

Current Assets 47.3m
Cash & Short-Term Investments 37.1m
Receivables 5.2m
Other Current Assets 5.1m
Non-Current Assets 49.1m
PP&E 1.9m
Intangibles 47m
Other Non-Current Assets 149k
Current Liabilities 12.5m
Accounts Payable 7.4m
Accrued Liabilities 111k
Other Current Liabilities 5m
Non-Current Liabilities 25.8m
Long-Term Debt 24.6m
Other Non-Current Liabilities 1.2m
Efficiency

Earnings Waterfall
DarioHealth Corp

Revenue
20.4m USD
Cost of Revenue
-14.4m USD
Gross Profit
6m USD
Operating Expenses
-62.2m USD
Operating Income
-56.2m USD
Other Expenses
-7.3m USD
Net Income
-63.5m USD

Free Cash Flow Analysis
DarioHealth Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

DRIO Profitability Score
Profitability Due Diligence

DarioHealth Corp's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Exceptional 3-Years Revenue Growth
ROIC is Increasing
Positive Gross Profit
26/100
Profitability
Score

DarioHealth Corp's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

DRIO Solvency Score
Solvency Due Diligence

DarioHealth Corp's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Negative Net Debt
45/100
Solvency
Score

DarioHealth Corp's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DRIO Price Targets Summary
DarioHealth Corp

Wall Street analysts forecast DRIO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DRIO is 5.78 USD with a low forecast of 4.04 USD and a high forecast of 8.4 USD.

Lowest
Price Target
4.04 USD
175% Upside
Average
Price Target
5.78 USD
293% Upside
Highest
Price Target
8.4 USD
471% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

DRIO Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

DRIO Price
DarioHealth Corp

1M 1M
-3%
6M 6M
+1%
1Y 1Y
-55%
3Y 3Y
-93%
5Y 5Y
-90%
10Y 10Y
-100%
Annual Price Range
1.47
52w Low
1
52w High
4.33
Price Metrics
Average Annual Return 0.04%
Standard Deviation of Annual Returns 95.07%
Max Drawdown -97%
Shares Statistics
Market Capitalization 40m USD
Shares Outstanding 29 442 500
Percentage of Shares Shorted 5.19%

DRIO Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

DarioHealth Corp Logo
DarioHealth Corp

Country

United States of America

Industry

Health Care

Market Cap

40m USD

Dividend Yield

0%

Description

DarioHealth Corp. is a digital therapeutics company, which engages in the research, development, and sale of pharmaceutical products. The company is headquartered in New York City, New York and currently employs 200 full-time employees. The company went IPO on 2013-03-08. DarioHealth operates at the intersection of life sciences, behavioral science, and software technology to deliver integrated and engaging digital therapeutics interventions. DarioHealth offers digital therapeutics solutions covering multiple chronic conditions including diabetes, hypertension, weight management, musculoskeletal and behavioral health within one integrated technology platform. Its products include Dario Blood Glucose Monitoring Starter Kit and Dario Blood Pressure Monitoring System. Its Dario Blood Glucose Monitoring Starter Kit is pocket-sized smartphone blood glucose meter that measure sugar levels. Its Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows to store all your readings in the Dario App. Its Dario mobile application, the Dario Blood sugar (glucose) meter enables to track and check blood sugar (glucose) in real-time.

Contact

NEW YORK
New York City
18 W 18Th St., 5Th Floor
+16466654667.0
http://mydario.com

IPO

2013-03-08

Employees

200

Officers

CEO & Director
Mr. Erez Raphael
President
Mr. Richard A. Anderson
CFO, Treasurer & Secretary
Mr. Zvi Ben David
Co-Founder & Production Chief
Dov Oppenheim
Chief Operating Officer
Mr. Tomer Ben-Kiki
Senior Vice President of Operations & Compliance
Josh Fischer
Show More
Content & Communications Manager
Claudia Levi
Vice President of Marketing
Mary Mooney
Chief People Officer
Limor Drezner
Head of Commercialization North America
Mr. Jean Christophe Muyl
Show Less

See Also

Discover More
What is the Intrinsic Value of one DRIO stock?

The intrinsic value of one DRIO stock under the Base Case scenario is 6.21 USD.

Is DRIO stock undervalued or overvalued?

Compared to the current market price of 1.47 USD, DarioHealth Corp is Undervalued by 76%.